Published in

Wiley, Magnetic Resonance in Medicine, 2024

DOI: 10.1002/mrm.30152

Links

Tools

Export citation

Search in Google Scholar

Digital reference object toolkit of breast DCE MRI for quantitative evaluation of image reconstruction and analysis methods

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

AbstractPurposeTo develop a digital reference object (DRO) toolkit to generate realistic breast DCE‐MRI data for quantitative assessment of image reconstruction and data analysis methods.MethodsA simulation framework in a form of DRO toolkit has been developed using the ultrafast and conventional breast DCE‐MRI data of 53 women with malignant (n = 25) or benign (n = 28) lesions. We segmented five anatomical regions and performed pharmacokinetic analysis to determine the ranges of pharmacokinetic parameters for each segmented region. A database of the segmentations and their pharmacokinetic parameters is included in the DRO toolkit that can generate a large number of realistic breast DCE‐MRI data. We provide two potential examples for our DRO toolkit: assessing the accuracy of an image reconstruction method using undersampled simulated radial k‐space data and assessing the impact of the field inhomogeneity on estimated parameters.ResultsThe estimated pharmacokinetic parameters for each region showed agreement with previously reported values. For the assessment of the reconstruction method, it was found that the temporal regularization resulted in significant underestimation of estimated parameters by up to 57% and 10% with the weighting factor λ = 0.1 and 0.01, respectively. We also demonstrated that spatial discrepancy of and increase to about 33% and 51% without correction for field.ConclusionWe have developed a DRO toolkit that includes realistic morphology of tumor lesions along with the expected pharmacokinetic parameter ranges. This simulation framework can generate many images for quantitative assessment of DCE‐MRI reconstruction and analysis methods.